Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 8
296
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of new 1,3-thiazol derivatives of maleopimaric acid as anticancer, antibacterial and antifungal agents

ORCID Icon, ORCID Icon, , , , , & show all
Pages 1340-1348 | Received 12 Apr 2019, Accepted 20 Jul 2019, Published online: 20 Aug 2019
 

Abstract

A series of new 1,3-thiazole derivatives of maleopimaric acid 6a–f, 7a–f were synthesized and evaluated for anticancer, antibacterial and antifungal activities. Evaluation of cytotoxic activity against human embryonic kidney 293 cells (HEK293), human neuroblastoma cell line (SH-SY5Y), hepatocellular carcinoma cell line (HepG2) and human T-cell lymphoblast-like line (Jurkat), showed that introduction of the aminothiazole fragment at position 6 of the diterpenoid molecule leads to decrease of cell viability. Substance 3 was found to be the most active against all tested cell lines, inhibiting cell viability with IC50 values in the range of 2–24 μM. The structure–activity relationship of these compounds was studied and the results show that the compounds 6c and 7e exhibited in vitro antifungal activity against Candida albicans and also possessed antibacterial profile against Enterobacter aerogenes, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli and Proteus vulgaris.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by State assignments № AAAA-A17-117011910025-6, № AAAA-A17-117011910027-0 and № AAAA-A16-116020350033-8. Experiments were carried out using the equipment of Collective Use Service Centers «Chemistry» and «Biomics».

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.